BioXcel Therapeutics – Developing Drugs in Neuroscience and Immuno-Oncology
Robert Risinger, Chief Medical Officer, Neuroscience at BioXcel Therapeutics, a biopharmaceutical company that uses artificial intelligence (AI) to iden...
5347 articles
Robert Risinger, Chief Medical Officer, Neuroscience at BioXcel Therapeutics, a biopharmaceutical company that uses artificial intelligence (AI) to iden...
Jamie McCoy, General Manager of Theranostics and Radiotherapeutics at GE HealthCare discusses theranostics and how it is changing the treatment of prost...
Allison McMullen, PhD, Scientific Partner for Molecular Diagnostics at Roche Diagnostics discusses a survey that shows that many Americans are confused ...
Arik Eisenkraft, MD., VP Clinical & Regulation at Biobeat, a digital tech company developing its proprietary data collection tools for remote patient mo...
David Harrell, Chairman and CEO of TranspareRX, the leading healthcare technology company bringing transparency to prescription drug pricing discusses C...
Cardiologists at Northwestern Medicine are using AI to identify patients with advanced heart failure who require specialized care, including those who m...
Deborah Young, director of the Division of Behavioral Research for the Kaiser Permanente Southern California Department of Research & Evaluation discuss...
Whether healthcare workers are on the front-line treating patients or working behind the scenes, the ability to successfully navigate change, rise above...
Anas Younes, Senior Vice President, Head of Haematology R&D, at AstraZeneca, discusses building a broad portfolio to target different hematological canc...
Therapy, in its many forms, has long been recognized as an essential tool in managing mental health, improving relationships, navigating life transition...